Karyopharm Therapeutics Inc. (KPTI)
KPTI Stock Chart More Charts
KPTI Price/Volume Stats
| Current price | $13.11 |
| Prev. close | $12.62 |
| Day low | $12.53 |
| Day high | $13.35 |
| 50-day MA | $17.61 |
| 200-day MA | $16.00 |
| 52-week high | $21.71 |
| 52-week low | $9.00 |
| Volume | 2,479,600 |
| Avg. volume | 643,930 |
| Dividend yield | N/A |
| Market Cap | 793.94M |
KPTI Returns
| 1-mo | -27.17% |
| 3-mo | -31.68% |
| 6-mo | -10.14% |
| 1-year | 14.70% |
| 3-year | 3.15% |
| 5-year | N/A |
| YTD | 36.56% |
| 2017 | 2.13% |
| 2016 | -29.06% |
| 2015 | -64.60% |
| 2014 | 63.31% |
| 2013 | N/A |
Karyopharm Therapeutics Inc. (KPTI) Company Bio
Karyopharm Therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. The company was founded in 2008 and is based in in Newton, Massachusetts.
Loading social stream, please wait...